Retrospective analysis of CA19-9 decrease in patients with metastatic pancreatic carcinoma (MPC) treated with FOLFIRINOX or gemcitabine (gem) in a randomized phase III study (ACCORD11/PRODIGE4)

Marie Robert; Marta Jarlier; Thierry Conroy; Sophie Gourgou; Françoise Desseigne; Marc Ychou; Olivier Bouche; Beata Juzyna; Jaafar Bennouna; Unicancer GI; PRODIGE Intergroup

doi:10.1200/jco.2014.32.15_suppl.4115

Retour

Retrospective analysis of CA19-9 decrease in patients with metastatic pancreatic carcinoma (MPC) treated with FOLFIRINOX or gemcitabine (gem) in a randomized phase III study (ACCORD11/PRODIGE4)

Article de revue

Avec comité de lecture

Retrospective analysis of CA19-9 decrease in patients with metastatic pancreatic carcinoma (MPC) treated with FOLFIRINOX or gemcitabine (gem) in a randomized phase III study (ACCORD11/PRODIGE4)

Marie Robert, Marta Jarlier, Thierry Conroy, Sophie Gourgou, Françoise Desseigne, Marc Ychou, Olivier Bouche, Beata Juzyna, Jaafar Bennouna et Unicancer GI; PRODIGE Intergroup

Journal of clinical oncology, Vol.32(15_suppl), pp.4115-4115

20/05/2014

DOI: https://doi.org/10.1200/jco.2014.32.15_suppl.4115

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Titre: Retrospective analysis of CA19-9 decrease in patients with metastatic pancreatic carcinoma (MPC) treated with FOLFIRINOX or gemcitabine (gem) in a randomized phase III study (ACCORD11/PRODIGE4)
Créateurs - sans rôle: Marie Robert - Institut de cancérologie de l'Ouest, Nantes, France
Marta Jarlier - CRLC Val d'Aurelle, Montpellier, France
Thierry Conroy - Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France
Sophie Gourgou - Biostatistics Unit – CTD INCa, Montpellier Cancer Institute, Montpellier, France
Françoise Desseigne - Centre Léon Bérard
Marc Ychou - Montpellier Cancer Institute, Montpellier, France
Olivier Bouche - Centre Hospitalier Universitaire Robert Debré, Reims, France
Beata Juzyna - UNICANCER, Paris, France
Jaafar Bennouna - Institut de Cancérologie de l'Ouest
Unicancer GI; PRODIGE Intergroup
Détails de publication: Journal of clinical oncology, Vol.32(15_suppl), pp.4115-4115
Identifiants: 99141169609311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article